Find side effects reporting information at the bottom of this page 
If you are a UK Healthcare Professional, please visit our Healthcare Professional website here
This website is for UK members of the public, patients prescribed Boehringer Ingelheim medicines and their carers.

Trajenta® (linagliptin

picture of woman smiling

Trajenta® (linagliptin)

This section is intended to provide reference information for UK members of the public, patients and their carers. It is not to replace the opinion of a healthcare professional.

Type 2 Diabetes

There are two main types of diabetes: Type 1 and Type 2. Type 2 Diabetes is the most common: 9 out of 10 people who have diabetes will have Type 2 Diabetes. It usually starts after the age of 40, but it can affect younger people as well. It is a condition that comes from both your genes and lifestyle.1,2

Type 2 Diabetes tends to develop gradually (over weeks or months). This is because in Type 2 Diabetes you still make insulin (unlike in Type 1 Diabetes). If you have Type 2 Diabetes this leads to high levels of glucose (sugar) in your blood.

Type 2 Diabetes can be caused by:

  • The pancreas not making enough insulin to control blood sugar levels
  • The cells in the body being less able to respond to insulin (called insulin resistance)
  • a combination of both

This results in high levels of glucose in your blood which can lead to long-term medical problems like heart disease, stroke, kidney disease, blindness and poor circulation in your limbs. If you have Type 2 Diabetes it is important to keep your blood glucose levels as close to normal as possible and to have a healthy lifestyle, to reduce this risk.

high-blood-glucose

References

  1. Type 2 diabetes Available at: https://www.diabetes.org.uk/type-2-diabetes (accessed November 2024)

  2. Preventing type 2 diabetes and risk factors. Available at: https://www.diabetes.org.uk/preventing-type-2-diabetes/diabetes-risk-factors (accessed November 2024)

Where can I find more information?

Patient Information Leaflet

The Patient Information Leaflet is the leaflet included in the pack with a medicine. It is written for patients and gives information about taking or using this medicine. It is possible that the leaflet in your medicine pack may differ from this version because it may have been updated since your medicine was packaged.

Summary of Product Characteristics

The Summary of Product Characteristics tells healthcare professionals, such as doctors, pharmacists and nurses, how to prescribe and use this medicine correctly. The information in the Patient Information Leaflet and Summary of Product Characteristics are not intended to replace the opinion of a healthcare professional.

NP-GB-105211 V2 | December 2024

picture of man typing on laptop

Side effects

If you get any side effects, talk to your doctor, pharmacist or nurse. This
includes any side effects not listed in package leaflet.
You can also report side effects directly to the Yellow Card scheme
of www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more information on the safety of the medicine.